Hollier Lisa M, Straub Heather
Department of Obstetrics and Gynecology, University of Texas, Houston Medical School, Houston, TX, USA.
BMJ Clin Evid. 2011 Apr 15;2011:1603.
Genital herpes is an infection with herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2), and is among the most common sexually transmitted diseases.
We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of interventions to prevent sexual transmission of herpes simplex virus? What are the effects of interventions to prevent transmission of herpes simplex virus from mother to neonate? What are the effects of antiviral treatment in people with a first episode of genital herpes? What are the effects of interventions to reduce the impact of recurrence? What are the effects of treatments in people with genital herpes and HIV? We searched: Medline, Embase, The Cochrane Library, and other important databases up to January 2010 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
We found 35 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
In this systematic review we present information relating to the effectiveness and safety of the following interventions: antivirals, caesarean delivery, condoms, oral aciclovir, psychotherapy, recombinant glycoprotein vaccines, serological screening, and counselling.
生殖器疱疹是由1型单纯疱疹病毒(HSV - 1)或2型单纯疱疹病毒(HSV - 2)引起的感染,是最常见的性传播疾病之一。
我们进行了一项系统评价,旨在回答以下临床问题:预防单纯疱疹病毒性传播的干预措施有哪些效果?预防单纯疱疹病毒从母亲传播给新生儿的干预措施有哪些效果?首次发作的生殖器疱疹患者接受抗病毒治疗有哪些效果?减少复发影响的干预措施有哪些效果?生殖器疱疹合并HIV感染者接受治疗有哪些效果?我们检索了:截至2010年1月的Medline、Embase、Cochrane图书馆及其他重要数据库(Clinical Evidence综述会定期更新,请查看我们的网站获取本综述的最新版本)。我们纳入了来自美国食品药品监督管理局(FDA)和英国药品及医疗产品监管局(MHRA)等相关组织的危害警示。
我们找到了35项符合我们纳入标准的系统评价、随机对照试验或观察性研究。我们对干预措施的证据质量进行了GRADE评估。
在本系统评价中,我们提供了以下干预措施有效性和安全性的相关信息:抗病毒药物、剖宫产、避孕套、口服阿昔洛韦、心理治疗、重组糖蛋白疫苗、血清学筛查及咨询。